登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
NH2OH · HCl
化学文摘社编号:
分子量:
69.49
UNSPSC Code:
12352301
NACRES:
NA.22
PubChem Substance ID:
EC Number:
226-798-2
Beilstein/REAXYS Number:
3539763
MDL number:
Assay:
99.999% trace metals basis
Grade:
ACS reagent (specifications)
grade
ACS reagent (specifications)
Quality Level
assay
99.999% trace metals basis
form
crystals
impurities
≤0.005% S compounds, ≤0.25 meq/g Titr. free acid, <10 ppm total metallic impurities
ign. residue
≤0.05%
pH
2.5-3.5 (20 °C, 50 g/L)
mp
155-157 °C (dec.) (lit.)
density
1.67 g/mL at 25 °C (lit.)
cation traces
Fe: ≤5 ppm, NH4+:, passes test, heavy metals: ≤5 ppm
SMILES string
Cl.NO
InChI
1S/ClH.H3NO/c;1-2/h1H;2H,1H2
InChI key
WTDHULULXKLSOZ-UHFFFAOYSA-N
Application
制备反应物:
- 有机硅烷胺作为甲型流感病毒 M2 质子通道的有效抑制剂和结构探针
- Lamellarin D 类似物作为拓扑异构酶 I 的抑制剂和潜在的抗肿瘤剂
- Azapeptide 宫缩抑制剂作为前列腺素 F2a 受体的抑制剂,用于预防早产
- 与吲哚啉-2-酮螺旋稠合的噻唑烷酮作为结核分枝杆菌蛋白酪氨酸磷酸酶 B 的有效和选择性抑制剂
- 基于口服生物可利用的基于喹啉的抗糖尿病二肽基肽酶 IV 抑制剂,靶向 Lys554
- 嘧啶核苷衍生物与一氧化氮供体,作为抗病毒剂
- 苄基腺苷化合物靶向腺苷 A2A 受体和腺苷转运蛋白,用于神经保护
- 萘酚衍生物作为香草素受体 TRPV1 的抑制剂,在尿失禁的大鼠膀胱测压模型中具有改善的效力
Biochem/physiol Actions
MAO 抑制剂;抑制血小板聚集。
Features and Benefits
符合 A.C.S. 的试剂规范。
Still not finding the right product?
Explore all of our products under 羟胺 盐酸盐
signalword
Warning
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 2 - Carc. 2 - Eye Irrit. 2 - Met. Corr. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 2 Oral
target_organs
spleen
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
存储类别
8B - Non-combustible corrosive hazardous materials
Lizethly Cáceres-Jensen et al.
International journal of environmental research and public health, 18(12) (2021-07-03)
The sorption behavior of 2,4-dichlorophenoxyacetic acid (2,4-D) in the abundant agricultural volcanic ash-derived soils (VADS) is not well understood despite being widely used throughout the world, causing effects to the environment and human health. The environmental behavior and risk assessment
Hironobu Maezaki et al.
Bioorganic & medicinal chemistry, 19(15), 4482-4498 (2011-07-12)
Dipeptidyl peptidase IV (DPP-4) inhibition is a validated therapeutic option for type 2 diabetes, exhibiting multiple antidiabetic effects with little or no risk of hypoglycemia. In our studies involving non-covalent DPP-4 inhibitors, a novel series of quinoline-based inhibitors were designed
Shi, J.; et al.
Chinese Chemical Letters = Zhongguo Hua Xue Kuai Bao, 22, 899-899 (2011)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 431362-50G | 04061832108261 |
| 431362-250G | 04061832108254 |



